WATCH: The New Normal: Search for a Cure - Dr. Phil Dormitzer of Pfizer
Phil Dormitzer sheds light on the news that Pfizer's early data is 90% effective against the coronavirus.
•
Nov 11, 2020, 3:08 PM
•
Updated 1,353 days ago
Share:
More Stories
Hometown Heroes in New York City
2ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
317ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
331ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
332ds agoHometown Heroes in New York City
2ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
298ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
310ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
317ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
331ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
332ds agoNews 12's Beth Cefalu talks to Dr. Phil Dormitzer as he sheds light on the news that Pfizer's early data is 90% effective against the coronavirus. Here's a full breakdown of important questions and answers from the interview.
Explain the 90% effective rate
Why does it work based on small group of people?
What happens after 164 participants test positive in the trials?
Did any participants have COVID prior to the trials?
The differences between the vaccine vs. placebo
When is the next analysis?
Explain how the trial relates to different ethnic groups
How do you choose who participates in phase 3 trials?
Explain the ethnic makeup of the trial
Explain some of the challenges of distribution
How is Pfizer overcoming the distribution challenges?
How long is the vaccine effective? What happens if the virus mutates?
Does competition from other companies help or hurt the process?
Have trials on children started?
How is immunity among children and the elderly?
What about people who are hesitant to take a vaccine?
What are the thoughts on politics surrounding the vaccine?
Is the vaccine effective against those not experiencing symptoms?
